0001209191-20-050028.txt : 20200910 0001209191-20-050028.hdr.sgml : 20200910 20200910180553 ACCESSION NUMBER: 0001209191-20-050028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200908 FILED AS OF DATE: 20200910 DATE AS OF CHANGE: 20200910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILSON TROY EDWARD CENTRAL INDEX KEY: 0001589597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 201169463 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 3033 SCIENCE PARK RD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-08 0 0001422143 Kura Oncology, Inc. KURA 0001589597 WILSON TROY EDWARD C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 1 1 0 0 President and CEO Common Stock 2020-09-08 4 S 0 50000 26.00 D 306736 I by Araxes Pharma LLC Common Stock 2020-09-10 4 S 0 1025 28.00 D 305711 I by Araxes Pharma LLC Common Stock 2020-09-10 4 M 0 37030 6.15 A 65126 D Common Stock 2020-09-10 4 S 0 37030 28.00 D 28096 D Common Stock 1795017 I by Red Fish Blue Fish Revocable Trust Option to purchase common stock 6.15 2020-09-10 4 M 0 37030 0.00 D 2027-01-22 Common Stock 37030 174947 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. This option vests in 48 equal monthly installments commencing on January 23, 2017. James Basta, Attorney-in-fact for Troy E. Wilson 2020-09-10